DrugChatter: What chemical changes did apotex introduce in ruxolitinib s formulation?
The Evolution of Ruxolitinib: Apotex's Innovative Formulation ChangesRuxolitinib, a Janus kinase (JAK) inhibitor, has revolutionized the treatment of myelofibrosis and polycythemia vera. Since its introduction, the drug has undergone significant f…
DrugChatter: What chemical changes did apotex introduce in ruxolitinib s formulation? Read Post »